Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Myeloproliferative Disorders 1

Interventions

ruxolitinib 3venetoclax 1veliparib 1pevonedistat 1navitoclax 1givinostat hydrochloride 1givinostat 1fludarabine phosphate 1bomedemstat 1anagrelide 1Whole-Body Irradiation 1Valganciclovir 1Topotecan 1Therapeutics 1Tacrolimus 1Sirolimus 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Methotrexate 1Melphalan 1INCB057643 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Etoposide 1Drug Evaluation 1Cyclosporine 1Cyclophosphamide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Thrombocythemia, Essential × givinostat × Clear all
NCT01761968 2025-04-30

Long-term Study Evaluating the Effect of Givinostat in Patients With Chronic Myeloproliferative Neoplasms

Italfarmaco

Phase 2 Active not recruiting
90 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡